
Mark Olfson, MD, MPH
Advertisement
Articles by Mark Olfson, MD, MPH

Advertisement
Latest Updated Articles
New Options in the Pharmacological Management of Attention-Deficit/Hyperactivity DisorderPublished: July 1st 2004 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
2
Patients Face New Care Complexities as DTC Options Expand
3
Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers
4
Louisiana Delivers Innovative Cancer Treatments, but Ensuring Access Is a Work in Progress
5



